VERONICA A COVALESKY

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease PHILA, PA NPI 1619947553

General Payments — all program years on this page

$923.23

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 24
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $635.69 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $635.6919

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $133.813
2020 $23.721
2023 $130.011
2024 $635.6919

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086703543 Novartis Pharmaceuticals Corporation $16.02 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086703547 Novartis Pharmaceuticals Corporation $19.03 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086703553 Novartis Pharmaceuticals Corporation $22.49 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086703555 Novartis Pharmaceuticals Corporation $19.34 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086703573 Novartis Pharmaceuticals Corporation $15.42 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086703575 Novartis Pharmaceuticals Corporation $22.61 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096632972 Novo Nordisk Inc $24.89 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096715703 Novo Nordisk Inc $22.87 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096891627 Novo Nordisk Inc $24.20 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097007566 Novo Nordisk Inc $21.93 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097190514 Novo Nordisk Inc $18.89 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118083444 Boehringer Ingelheim Pharmaceuticals, Inc. $24.50 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129431894 Esperion Therapeutics, Inc. $20.84 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135488474 Lilly USA, LLC $28.25 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138797482 Edwards Lifesciences Corporation $131.14 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144688142 GE HEALTHCARE $120.41 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144690185 GE HEALTHCARE $33.34 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144690355 GE HEALTHCARE $33.34 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154054776 iRhythm Technologies, Inc. $16.18 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.